Melatonin in Obese Patients in Laparoscopic Cholecystectomy - Trial NCT06355687
Access comprehensive clinical trial information for NCT06355687 through Pure Global AI's free database. This phase not specified trial is sponsored by Ain Shams University and is currently Not yet recruiting. The study focuses on Anesthesia. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ain Shams University
Timeline & Enrollment
N/A
Apr 01, 2024
Apr 01, 2025
Primary Outcome
Postoperative Pain.
Summary
Opioid free anesthesia (OFA) means a technique in which no intraoperative opioid is
 administered through any route. Perioperative pain management in an obese patient is
 challenging. The incidence of respiratory depression is higher in obese patients and is
 exaggerated with opioids, so the investigators are searching for a drug that has analgesic
 effect without any effect on respiratory function. In this study, the investigators will add
 melatonin to OFA in obese patients undergoing laparoscopic cholecystectomy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06355687
Non-Device Trial